Summary
Eighteen previously untreated patients with advanced unresectable or metastatic soft-tissue sarcomas (STS) and two patients with locally invasive thymoma were treated with a combination of adriamycin (ADM) 80 mg/m2 on day 1 and cis-platinum (DDP) 120 mg/m2 on day 1. The regimen was repeated at 4-weeks intervals. In STS the overall remission rate was 44%, with 21% complete remissions. The overall survival was 15 months (3–35+), responders surviving a median of 20 months (3–35+) and nonresponders, a median of 9 months (3–20+).
Tumor responses lasted a median of 8 months (3–35+).
Two patients with liposarcoma have now survived disease-free for at least 2 years and are potentially cured.
The two patients with thymoma experienced complete remission lasting 4+ and 20+ months.
Substantial hematologic toxicity was prominent, due to the high-doses used in this combination regimen.
Similar content being viewed by others
References
Bierbaum W, Bremer K, Firusian N, Higi M, Niederle N, Scheulen ME, Schmidt CG, Seeber S (1981) Chemotherapeutische Behandlungsmöglichkeiten bei fortgeschrittenen Sarkomen. Dtsch med Wochenschr 106:1181
Blum RH, Corson JM, Wison RE, Greenberger JS, Canellos GP, Frei E III (1980) Successful treatment of metastatic sarcomas with cyclophosphamide, adriamycin and DTIC (CAD). Cancer 46:1722
Bodey GP, Rodriguez V, Murphy WK, Burgess A, Benjamin RS (1981) Protected environment-prophylactic antibiotic program for malignant sarcomas. Cancer 47:2422
Bramwell VHE, Brugordas A, Mouridsen HT, Cheix F, De Jager R, van Oosterom AT, Vendrik CP, Pinedo HM, Sylvester R, De Pauw M (1979) EORTC Phase II study of cisplatin in CYVADIC-resistant soft tissue sarcomas. Eur J Cancer 15:1511
Cortes EP, Holland JF, Wang JJ, Glidewell O (1975) Adriamycin (NSC-123127) in 87 patients with osteosarcoma. Cancer Chemother Rep 6:305
Gehan EH (1965) A generalized Wilcoxon test for arbitrary single-censored samples. Biometrics 52:203
Gottlieb JA, Baker LH, O'Bryan RM, Sinkovics B, Hoogstraten Blumenschein GR, Saiki JH, Coltman C, Burgess MA, Sullivan P, Thigpen T, Bottomley R, Balcerzak S, Moon TE (1975) Adriamycin (NSC-123127) used alone and in combination for soft tissue and bony sarcomas. Cancer Chemother Rep [3] 6:271
Gottlieb JA, Benjamin RS, Baker LH (1976) Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. Cancer Treat Rep 69:199
Guiliano AE, Larkin F, Eilber FR, Morton DL (1978) Failure of combination chemotherapy (CYVADIC) in metastatic soft tissue sarcomas. Implications for adiuvant studies. (Abstract C-212) Proc AACR/ASCO 19:359
Jaffrey IS, Denefrio J, Chahinian C (1981) Treatment of invasive or metastatic thymoma. Cancer 47:1752
Kaplan EL, Meier P (1958) Non-parametric estimation for incomplete observations. J Am Stat Assoc 53:457
Karakusis CP (1982) Soft tissue sarcomas. An update. Current Surgery 39:5
Karakusis CP, Holtermann OA, Hoyoke ED (1979) cis-Dichlorodiammineplatinum (II) in metastatic soft tissue sarcomas. Cancer Treat Rep 63:2071
O'Bryan RM, Baker LH, Gottlieb JE (1977) Dose response evaluation of adriamycin in human neoplasia. Cancer 39:1940
Pinedo HM, van Oosterom AT (1980) Treatment of advanced soft tissue sarcomas in adults. In: van Oosterom AT, Muggia FM, Cleton J (eds) Therapeutic progress in overian cancer, testicular cancer and the sarcomas. University Press, Leiden, p 425
Rosenberg SA, Suit HD, Baker LA, Rosen G (1982) Sarcomas of the soft tissue and bone. In: de Vita VT, Hellman S, Rosenberg SA (eds) Cancer. Principles and practice of oncology. Lippincott, Philadelphia Toronto, p 1037
Russell WO, Cohan J, Enzinger F, Hajdu SI, Heise H, Martin R, Meissner W, Miller WT, Schmitz RL, Suit HD (1977) A clinical and pathological staging system for soft tissue sarcomas. Cancer 40:1562
Mitrou PS, Bergmann L, Tuengerthal S (1982) Induktion einer kompletten Remission mit Adriamycin und cis-Platin bei einem invasiv wachsenden Thymom. Dtsch med Wochenschr 44:1667
Samson MK, Baker LH, Benjamin RS, Lane M, Plager C (1979) cis-Dichlorodiammineplatinum (II) in advanced soft tissue and bony sarcomas: A Southwest Oncology Group Study. Cancer Treat Rep 63:2027
Shetty MR, Aurora RK (1981) Invasive thymoma treated with cis-platinum. Cancer Treat Rep 65:531
Yap BS, Baker H, Sinkovics JG, Rivkin SE, Bottomley R, Thigpen T, Burgess MA, Benjamin RS, Bodey GP (1980) Cyclophosphamide, vincristine, adriamycin and DTIC (CYVADIC) combination chemotherapy for treatment of advanced sarcomas. Cancer Treat Rep 64:93
Yap BS, Sincovics JG, Burgess MA, Benjamin RS, Bodey GP (1983) The curability of advanced soft tissue sarcomas in adults with chemotherapy (Abstract C-937). Proc Am Soc Clin Oncol 2:239
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Klippstein, T.H., Mitrou, P.S., Kochendörfer, K.J. et al. High-dose adriamycin (ADM) and cis-platinum (DDP) in advanced soft-tissue sarcomas and invasive thymomas. Cancer Chemother. Pharmacol. 13, 78–81 (1984). https://doi.org/10.1007/BF00257118
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00257118